Patent application number | Description | Published |
20090082204 | Controlled release insecticidal formulations - The present invention relates generally to insecticidal formulations, and, in one embodiment, to point source controlled release insecticidal formulations, particularly those insecticides that are agonists or antagonists of nicotinergic acetylcholine receptors, and still more particularly, imidacloprid, and to a method and apparatus for point sourcing the same. | 03-26-2009 |
20090099247 | Use of tetramic acid derivatives for controlling pets by drenching, drip application, dip application or soil injection - Compounds of the formula (I) in which A, B, G, W, X, Y and Z can have the meanings given in the description are highly suitable for controlling animal pests such as insects and/or spider mites and/or nematodes by treating the soil/growth substrate by drenching or drip application or dipping or soil injection. | 04-16-2009 |
20090215832 | Method of Combating Turf Pests With a Combination of Imidacloprid and Bifenthrin - This invention relates to a method of controlling surface insect pests of turf using bifenthrin and imidacloprid. | 08-27-2009 |
20110046196 | Insecticidal Fertilizer Mixtures - This invention relates to insecticidal fertilizer mixtures containing | 02-24-2011 |
20120035220 | Method of Fungal Pathogen Control in Grass or Turf - Disclosed is a method of controlling fungal organisms in turfgrass with imidacloprid and optionally one or more other fungicides. | 02-09-2012 |
20120035221 | Method of Fungal Pathogen Control in Grass or Turf - Disclosed is a method of controlling fungal organisms in turfgrass with imidacloprid and optionally one or more other fungicides. | 02-09-2012 |
20120178786 | Use of tetramic acid derivatives for controlling pests by drenching, drip application, or dip application - Compounds of the formula (I) in which A, B, G, W, X, Y and Z can have the meanings given in the description are highly suitable for controlling animal pests such as insects and/or spider mites and/or nematodes by treating the soil/growth substrate by drenching or drip application or dipping or soil injection. | 07-12-2012 |
Patent application number | Description | Published |
20090186917 | 6-And 7-amino isoquinoline compounds and methods for making and using the same - 6- and 7-amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6- and 7-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided. | 07-23-2009 |
20100022585 | BETA- AND GAMMA-AMINO-ISOQUINOLINE AMIDE COMPOUNDS AND SUBSTITUTED BENZAMIDE COMPOUNDS - Disclosed are beta and gamma-amino isoquinoline amide compounds and substituted benzamide compounds. In particular, the invention provides compounds that affect the function of kinases in a cell and that are useful as therapeutic agents or with therapeutic agents. The compounds of the invention are useful in the treatment of a variety of diseases and conditions including eye diseases such as glaucoma, cardiovascular diseases, and diseases characterized by abnormal growth, such as cancers. The invention further provides compositions containing the beta or gamma-amino isoquinoline amide compounds or substituted benzamide compounds. | 01-28-2010 |
20100137364 | 6-Aminoisoquinoline Compounds - 6-Amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided. | 06-03-2010 |
20100144713 | 6-AND 7-AMINO ISOQUINOLINE COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME - 6- and 7-amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6- and 7-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided. | 06-10-2010 |
20100228015 | PRODRUG DERIVATIVES OF ACIDS USING ALCOHOLS WITH HOMOTOPIC HYDROXY GROUPS AND METHODS FOR THEIR PREPARATION AND USE - This invention relates to novel homotopic prodrugs and medicaments and methods for their preparation, testing and use. In one embodiment, the homotopic prodrug has the general formula | 09-09-2010 |
20100280011 | DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE - Provided are compounds that are inhibitors of both rho kinase and of a monoamine transporter (MAT) act to improve the disease state or condition. Further provided are compositions comprising the compounds. Further provided are methods for treating diseases or conditions, the methods comprising administering compounds according to the invention. One such disease may be glaucoma for which, among other beneficial effects, a marked reduction in intraocular pressure (IOP) may be achieved. | 11-04-2010 |
20110183965 | 6-AMINOISOQUINOLINE COMPOUNDS - 6-Amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided. | 07-28-2011 |
20110319390 | 6-Aminoisoquinoline Compounds - 6-Amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided. | 12-29-2011 |